DHR
Danaher Corporation
NYSE: DHR · HEALTHCARE · DIAGNOSTICS & RESEARCH
$178.95
+0.08% today
Updated 2026-04-29
Market cap
$126.55B
P/E ratio
34.58
P/S ratio
5.11x
EPS (TTM)
$5.17
Dividend yield
0.76%
52W range
$175 – $242
Volume
4.3M
Danaher Corporation (DHR) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.60B | $11.03B | $12.70B | $11.18B | $13.20B | $16.09B | $18.26B | $19.12B | $19.91B | $14.43B | $16.88B | $18.33B | $17.05B | $17.91B | $22.28B | $29.45B | $26.64B | $23.89B | $23.88B | $24.57B |
| Revenue growth (YoY) | — | +14.9% | +15.2% | -11.9% | +18.0% | +21.9% | +13.5% | +4.7% | +4.2% | -27.5% | +17.0% | +8.6% | -7.0% | +5.1% | +24.4% | +32.2% | -9.5% | -10.3% | -0.1% | +2.9% |
| Cost of revenue | $5.35B | $5.99B | $6.72B | $5.78B | $6.58B | $7.85B | $8.81B | $9.13B | $9.43B | $6.52B | $7.50B | $8.10B | $7.54B | $7.93B | $9.81B | $11.50B | $10.46B | $12.22B | $9.67B | $9.60B |
| Gross profit | $4.24B | $5.04B | $5.97B | $5.40B | $6.63B | $8.24B | $9.45B | $9.98B | $10.49B | $7.91B | $9.38B | $10.23B | $9.51B | $9.98B | $12.47B | $17.95B | $16.19B | $14.03B | $14.21B | $14.97B |
| Gross margin | 44.2% | 45.7% | 47.0% | 48.3% | 50.2% | 51.2% | 51.7% | 52.2% | 52.7% | 54.8% | 55.6% | 55.8% | 55.8% | 55.7% | 56.0% | 61.0% | 60.8% | 58.7% | 59.5% | 60.9% |
| R&D | $446.00M | $601.42M | $725.44M | $632.65M | $809.48M | $1.02B | $1.14B | $1.25B | $1.31B | $861.40M | $975.10M | $1.13B | $1.06B | $1.13B | $1.35B | $1.74B | $1.53B | $1.50B | $1.58B | $1.60B |
| SG&A | $2.74B | $2.71B | $3.35B | $3.19B | $3.67B | $4.61B | $5.18B | $5.43B | $5.70B | $6.05B | $5.61B | $6.04B | $6.47B | $5.59B | $6.90B | $8.20B | $8.52B | $8.68B | $7.76B | $8.23B |
| Operating income | $1.51B | $1.73B | $1.95B | $1.73B | $2.23B | $2.74B | $3.20B | $3.37B | $3.60B | $2.42B | $2.99B | $3.15B | $3.07B | $3.36B | $4.31B | $8.05B | $7.54B | $5.20B | $5.18B | $5.14B |
| Operating margin | 15.7% | 15.7% | 15.4% | 15.5% | 16.9% | 17.0% | 17.5% | 17.6% | 18.1% | 16.8% | 17.7% | 17.2% | 18.0% | 18.8% | 19.4% | 27.3% | 28.3% | 21.8% | 21.7% | 20.9% |
| EBITDA | $1.74B | $2.02B | $2.22B | $1.89B | $2.86B | $3.22B | $4.01B | $4.61B | $4.54B | $3.06B | $3.92B | $4.34B | $4.28B | $4.60B | $6.54B | $10.01B | $9.48B | $5.20B | $7.28B | $6.95B |
| EBITDA margin | 18.2% | 18.3% | 17.5% | 16.9% | 21.7% | 20.0% | 21.9% | 24.1% | 22.8% | 21.2% | 23.2% | 23.7% | 25.1% | 25.7% | 29.4% | 34.0% | 35.6% | 21.8% | 30.5% | 28.3% |
| EBIT | $1.53B | $1.75B | $1.88B | $1.55B | $2.46B | $2.59B | $3.17B | $3.71B | $3.60B | $2.18B | $2.80B | $3.10B | $3.10B | $3.41B | $4.77B | $7.84B | $7.35B | $5.20B | $4.92B | $4.50B |
| Interest expense | $79.83M | $109.70M | $130.17M | $122.66M | $120.78M | $141.64M | $157.50M | $145.90M | $122.70M | $139.80M | $184.40M | $162.70M | $136.90M | $108.60M | $273.00M | $241.00M | $207.00M | $286.00M | $278.00M | $265.00M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $1.12B | $1.22B | $1.32B | $1.15B | $1.79B | $1.97B | $2.30B | $2.69B | $2.60B | $2.60B | $2.55B | $2.49B | $2.65B | $2.56B | $3.65B | $6.43B | $7.21B | $4.74B | $3.90B | $3.61B |
| Net income growth (YoY) | — | +8.8% | +8.0% | -12.6% | +55.7% | +9.9% | +16.6% | +17.3% | -3.6% | -0.1% | -1.7% | -2.4% | +6.4% | -3.5% | +42.6% | +76.4% | +12.1% | -34.2% | -17.8% | -7.3% |
| Profit margin | 11.7% | 11.1% | 10.4% | 10.3% | 13.6% | 12.2% | 12.6% | 14.1% | 13.0% | 18.0% | 15.1% | 13.6% | 15.5% | 14.3% | 16.4% | 21.8% | 27.1% | 19.9% | 16.3% | 14.7% |